Compounds > bradykinin, sar-(d-phe(8))des-arg(9)
Page last updated: 2024-09-05

bradykinin, sar-(d-phe(8))des-arg(9) and phosphoramidon

bradykinin, sar-(d-phe(8))des-arg(9) has been researched along with phosphoramidon in 1 studies

Compound Research Comparison

Studies
(bradykinin, sar-(d-phe(8))des-arg(9))		Trials
(bradykinin, sar-(d-phe(8))des-arg(9))		Recent Studies (post-2010)
(bradykinin, sar-(d-phe(8))des-arg(9))		Studies
(phosphoramidon)		Trials
(phosphoramidon)		Recent Studies (post-2010) (phosphoramidon)
18017811233

Protein Interaction Comparison

ProteinTaxonomybradykinin, sar-(d-phe(8))des-arg(9) (IC50)phosphoramidon (IC50)
ThermolysinBacillus thermoproteolyticus0.033
NeprilysinRattus norvegicus (Norway rat)0.0578
NeprilysinOryctolagus cuniculus (rabbit)0.0028
NeprilysinHomo sapiens (human)0.0405
Angiotensin-converting enzyme Homo sapiens (human)0.615
Endothelin-converting enzyme 1Homo sapiens (human)1.0695
P2Y purinoceptor 12Homo sapiens (human)0.017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daray, FM; Errasti, AE; Falcioni, AG; Gago, JE; Goldschmidt, ED; Nowak, W; Pelorosso, FG; Pugliese, MI; Rothlin, RP1

Other Studies

1 other study(ies) available for bradykinin, sar-(d-phe(8))des-arg(9) and phosphoramidon

ArticleYear
Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein.
    Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 375, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Captopril; CD13 Antigens; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Glycopeptides; Humans; In Vitro Techniques; Kallidin; Metalloproteases; Neprilysin; Peptides; Protease Inhibitors; Receptor, Bradykinin B1; Umbilical Veins; Vasoconstriction

2007